Catheter-based Endovascular Denervation beyond Hypertension: emerging field for IR

Coordinator(s)

• 

  Gao-Jun Teng, MD, FSIR

  President of the hospital
  Zhong-Da Hospital, Southeast University

  Disclosure(s): No financial relationships to disclose
• 

  Marc Sapoval, MD, PhD

  Head vascular and Oncological Interventional Radiology
  Hopital Europeen Georges Pompidou

  Disclosure(s): Medtronic: Consultant (Ongoing); Recor Otsuka: Board Membership (Ongoing), Consultant (Ongoing), Speaking and Teaching (Ongoing)

1. Update the renal denervation (RDN) treating in hypertention.
2. Endovascular denervation is not only used at renal artery for hypertention, but also used in other arteries such as celiac artery, hepatic artery, etc. for other diseases.
3. The catheter-based endovascular denervation for T2MD provides a new field for interventional radiologists.

Presentations:

• 3:00 PM – 3:15 PM

  Endovascular Celiac Denervation for Glycemic Control in Type 2 Diabetes Mellitus
  

  Speaker: Gao-Jun Teng, MD, FSIR – Zhong-Da Hospital, Southeast University
• 3:15 PM – 3:30 PM

  Comparative technical options for renal denervation
  

  Speaker: Marc Sapoval, MD, PhD – Hopital Europeen Georges Pompidou
• 3:30 PM – 3:45 PM

  Effects of Endovascular Denervation on Diet-Induced Glucose Intolerance: a Preclinical Study
  

  Speaker: Zhi Wang
• 3:45 PM – 4:00 PM

  Catheter-based renal denervation beyond hypertension – an emerging field?
  

  Speaker: Shaoliang Chen, MD – Nanjing First Hospital, Nanjing Medical University
• 4:00 PM – 4:15 PM

  Efficacy and safety of perirenal fat ablation with focused power ultrasound for lowering serum cholesterol in dyslipidemia patients at low-to-moderate cardiovascular risk (CONCISE): a randomized, double-blind, sham-controlled, clinical trial
  

  Speaker: Xiang-Qing Kong, Chief Division of Cardiology – The First Affiliated Hospital of Nanjing Medical University, China
• 4:15 PM – 4:30 PM

  Q & A